CLVT

Clarivate Plc

Fundamental data last updated:September 3, 2026

We may earn a commission from partner links. This content is for informational purposes only and is not financial advice. Information may be delayed or inaccurate.

company profile

SECTOR

Technology

industry

Information Technology Services

Exchange

NYSE

County of HQ

GB

Next Earnings Date

Pending Announcement

Business Summary

Clarivate Plc, an information services and analytics company, provides structured information and analytics for discovery, protection, and commercialization of scientific research, innovations, and brands. It offers Web of Science products and services, such as Web of Science, InCites, Journal Citation Reports, EndNote, ScholarOne, Converis, Publons, and Kopernio to organizations that plan, fund, implement, and utilize research; and Life Sciences products, including Cortellis and Newport Integrity for pharmaceutical and biotechnology companies to support research, market intelligence, and competitive monitoring in connection with the development and commercialization of new drugs. The company also provides Derwent products, which include Derwent Innovation, Techstreet, and IP Professional Services that enables its customers to evaluate the novelty of potential new products, confirm freedom to operate with respect to their product design, help them secure patent protection, assess the competitive technology landscape, and ensure that their products comply with required industry standards; CompuMark products, such as trademark screening, searching, and watching products and services for businesses and law firms; and MarkMonitor products, which helps enterprises to establish, manage, optimize, and protect their online presence. It serves government and academic institutions, life science companies, and research and development corporations in the Americas, the Middle East, Africa, Europe, and the Asia Pacific. The company was formerly known as Clarivate Analytics Plc and changed its name to Clarivate Plc in May 2020. Clarivate Plc is headquartered in London, the United Kingdom.

 


Analyze CLVT on TradingView

VALUATION

P/E

-11.89

Market Cap ($M USD)

$1.63B

Forward P/E

2.74

PEG

0.01

PRICE TO SALES

0.67

PRICE TO BOOK

0.34

EV / EBITDA

6.53

5-Year Average P/E

Free Cash Flow Yield

36.63%

DCF Value

$-7.52

Graham Number

N/A

Price to FCF

2.73

EV to FCF

9.60

Earnings Yield

-8.41%

FCF Yield

36.63%

DIVIDEND

Yield

0.00%

Annual Payout

$0.00

Payout Ratio

0.00%

Consecutive Years of Dividend Growth

5-Year Dividend Growth Rate

Financial Health & Profitability

Earnings Per Share

-$0.21

Next Year EPS Growth Estimate

$0.93

Next Year Revenue Growth Estimate

$2.48B

Return on Equity (ROE)

-2.81%

FREE CASH FLOW

Operating Margin

5.01%

Debt-to-Equity

0.92

Piotroski F-Score

6

Altman Z-Score

-0.57

Return on Invested Capital (ROIC)

1.31%

Current Ratio

0.84

Quick Ratio

0.84

Net Debt to EBITDA

4.67

Interest Coverage

0.47

Gross Profit margin

66.54%

FCF PER SHARE

$0.93

REVENUE PER SHARE

$3.82

Analyze CLVT on TradingView

Gainseekers Quantitative Analysis

Summary

The market seems to be mispricing Clarivate Plc, with its snapshot price trading significantly below its DCF value. The Forward P/E of 2.93 suggests a potential growth story, yet the negative Earnings Yield and Altman Z-score of -0.56 raise red flags about financial stability. Despite these concerns, the PEG Forward ratio of 0.0054 indicates the stock is undervalued relative to its growth prospects. The company’s valuation metrics paint a picture of a high-risk, high-reward scenario, with the market perhaps underestimating its future earnings potential.

AI Exposure / Tech Reliance

Positioned within the Information Technology Services industry, Clarivate Plc is well-suited to leverage AI advancements. The sector's inherent focus on data and analytics provides a natural pathway for integrating AI solutions. This adaptability could enhance their service offerings and operational efficiencies.

The Bull Case

For the value or GARP investor, Clarivate Plc offers compelling reasons to buy. With an ROIC of 1.31% and a robust FCF Yield of 33.60%, the company demonstrates efficient capital allocation and strong cash generation. The Piotroski F-Score of 6 suggests moderate financial health, while a Gross Profit Margin of 66.54% highlights significant pricing power. These metrics collectively suggest a company capable of delivering shareholder value through strategic growth and operational efficiency.

The Bear Case

Despite some strengths, Clarivate Plc faces significant structural risks. The negative Price/Earnings ratio and Return on Equity of -2.81% highlight profitability challenges. The Altman Z-score indicates potential financial distress, while the Interest Coverage ratio of 0.47 suggests vulnerability to debt obligations. These factors, combined with a Current Ratio below 1, point to liquidity concerns that could hinder long-term sustainability.

Market Sentiment & Smart Money

Short Interest %

Analyst Consensus

Hold

Average Analyst Price Target

$3.30

Institutional Ownership %

1-Year Beta

1.41

Insider Buying % (6 Mo)

Distance to 52-Week High

87.06%

Distance to 52-Week Low

34.90%

EARNINGS SURPRISE %

28.57%

50-DAY SMA

$2.54

200-DAY SMA

$3.17

⚠️ Financial Disclaimer:
This content is for informational purposes only and is not financial advice. Information may be delayed or inaccurate. We may earn a commission from partner links.